Katharina Dorothea Clementine Stärk

Katharina Dorothea Clementine Stärk

Auto-generated profile, based on publicly available information

Katharina Dorothea Clementine Stärk

SAFOSO AG, Waldeggstrasse 1, CH 3097 Bern Liebefeld, Switzerland

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2006 in BMC Health Services Research
Verified
Journal Article
Open access
KSKatharina Dc Stärk
Katharina Dc Stärk
GSGertraud Schüpbach-Regula
Gertraud Schüpbach-Regula
JHJorge Hernandez
Jorge Hernandez
LKLea Knopf
Lea Knopf
KFKlemens Fuchs
Klemens Fuchs
PDPeter Davies
Peter Davies
Background: Emerging animal and zoonotic diseases and increasing international trade have resulted in an increased demand for veterinary surveillance systems. However, human and financial resources available to support government veterinary services are becoming more and more limited in many countries world-wide. Intuitively, issues that present higher risks merit higher priority for surveillance resources as investments will yield higher benefit-cost ratios. The rapid rate of acceptance of this core concept of risk-based surveillance has outpaced the development of its theoretical and practical bases.Discussion: The principal objectives of risk-based veterinary surveillance are to identify surveillance needs to protect the health of livestock and consumers, to set priorities, and to allocate resources effectively and efficiently. An important goal is to achieve a higher benefit-cost ratio with existing or reduced resources. We propose to define risk-based surveillance systems as those that apply risk assessment methods in different steps of traditional surveillance design for early detection and management of diseases or hazards. In risk-based designs, public health, economic and trade consequences of diseases play an important role in selection of diseases or hazards. Furthermore, certain strata of the population of interest have a higher probability to be sampled for detection of diseases or hazards. Evaluation of risk-based surveillance systems shall prove that the efficacy of risk-based systems is equal or higher than traditional systems; however, the efficiency (benefit-cost ratio) shall be higher in risk-based surveillance systems.Summary: Risk-based surveillance considerations are useful to support both strategic and operational decision making. This article highlights applications of risk-based surveillance systems in the veterinary field including food safety. Examples are provided for risk-based hazard selection, risk-based selection of sampling strata as well as sample size calculation based on risk considerations.

1 April 2011 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
RCRichard Coker
Richard Coker
JRJonathan Rushton
Jonathan Rushton
SMSandra Mounier-Jack
Sandra Mounier-Jack
EKEsron Karimuribo
Esron Karimuribo
PLPascal Lutumba
Pascal Lutumba
MRMark Rweyemamu
Mark Rweyemamu

28 January 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
HBHouda Bennani
Houda Bennani
AMAna Mateus
Ana Mateus
NMNicholas Mays
Nicholas Mays
EEElizabeth Eastmure
Elizabeth Eastmure
KSKatharina D. C. Stärk
Katharina D. C. Stärk
Barbara HaeslerBarbara Haesler
Barbara Haesler
Antimicrobial resistance (AMR) is a global health problem. Bacteria carrying resistance genes can be transmitted between humans, animals and the environment. There are concerns that the widespread use of antimicrobials in the food chain constitutes an important source of AMR in humans, but the extent of this transmission is not well understood. The aim of this review is to examine published evidence on the links between antimicrobial use (AMU) in the food chain and AMR in people and animals. The evidence showed a link between AMU in animals and the occurrence of resistance in these animals. However, evidence of the benefits of a reduction in AMU in animals on the prevalence of resistant bacteria in humans is scarce. The presence of resistant bacteria is documented in the human food supply chain, which presents a potential exposure route and risk to public health. Microbial genome sequencing has enabled the establishment of some links between the presence of resistant bacteria in humans and animals but, for some antimicrobials, no link could be established. Research and monitoring of AMU and AMR in an integrated manner is essential for a better understanding of the biology and the dynamics of antimicrobial resistance.

1 February 2002 in Preventive Veterinary Medicine
Verified
Journal Article
Closed access
SMSten Mortensen
Sten Mortensen
HSHenrik Stryhn
Henrik Stryhn
RSRikke Søgaard
Rikke Søgaard
ABAnette Boklund
Anette Boklund
KSKatharina D.C Stärk
Katharina D.C Stärk
PWPreben Willeberg
Preben Willeberg

8 July 2008 in Acta Veterinaria Scandinavica
Verified
Journal Article
Open access
PDF file
RHRene S. Hendriksen
Rene S. Hendriksen
DMDik J Mevius
Dik J Mevius
ASAndreas Schroeter
Andreas Schroeter
CTChristopher Teale
Christopher Teale
DMDanièle Meunier
Danièle Meunier
FAFrank Møller Aarestrup
Frank Møller Aarestrup
The project "Antibiotic resistance in bacteria of animal origin – II" (ARBAO-II) was funded by the European Union (FAIR5-QLK2-2002-01146) for the period 2003–2005, with the aim to establish a continuous monitoring of antimicrobial susceptibility among veterinary laboratories in European countries based on validated and harmonised methodologies. Available summary data of the susceptibility testing of the bacterial pathogens from the different laboratories were collected.

1 August 2004 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
Regina Hofmann-LehmannRegina Hofmann-Lehmann
Regina Hofmann-Lehmann
MMMarina L. Meli
Marina L. Meli
UDUte M. Dreher
Ute M. Dreher
EGEnikö GönCzi
Enikö GönCzi
PDPeter Deplazes
Peter Deplazes
HLHans Lutz
Hans Lutz
Bovine anaplasmosis is a vector-borne disease that results in substantial economic losses in other parts of the world but so far not in northern Europe. In August 2002, a fatal disease outbreak was reported in a large dairy herd in the Swiss canton of Grisons. Diseased animals experienced fever, anorexia, agalactia, and depression. Anemia, ectoparasite infestation, and, occasionally, hemoglobinuria were observed. To determine the roles of vector-borne pathogens and to characterize the disease, blood samples were collected from all 286 animals: 50% of the cows were anemic. Upon microscopic examination of red blood cells,Anaplasma marginaleinclusion bodies were found in 47% of the cows. The infection was confirmed serologically and by molecular methods. Interestingly, we also found evidence of infections withAnaplasma phagocytophilum, largeBabesiaandTheileriaspp., andMycoplasma wenyonii. The last two species had not previously been described in Switzerland. Anemia was significantly associated with the presence of the infectious agents detected, with the exception ofA. phagocytophilum. Remarkably, concurrent infections with up to five infectious vector-borne agents were detected in 90% of the ill animals tested by PCR. We concluded thatA. marginalewas the major cause of the hemolytic anemia, while coinfections with other agents exacerbated the disease. This was the first severe disease outbreak associated with concurrent infections with vector-borne pathogens in alpine Switzerland; it was presumably curtailed by culling of the entire herd. It remains to be seen whether similar disease outbreaks will have to be anticipated in northern Europe in the future.